(GLAD) Gladstone Capital - Ratings and Ratios
Debt Instruments, Equity Stakes, Mezzanine Financing
Dividends
| Dividend Yield | 10.38% |
| Yield on Cost 5y | 19.66% |
| Yield CAGR 5y | 28.00% |
| Payout Consistency | 94.5% |
| Payout Ratio | 27.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 19.5% |
| Value at Risk 5%th | 33.4% |
| Relative Tail Risk | 3.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.58 |
| Alpha | -26.86 |
| CAGR/Max DD | 0.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.402 |
| Beta | 0.737 |
| Beta Downside | 0.907 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.56% |
| Mean DD | 7.64% |
| Median DD | 6.37% |
Description: GLAD Gladstone Capital October 23, 2025
Gladstone Capital Corporation (NASDAQ:GLAD) is a Business Development Company (BDC) that focuses on providing growth-capital and structured-finance solutions to lower-middle-market U.S. companies. Its investment scope includes senior and subordinated term loans, unitranche facilities, mezzanine debt, and equity-linked instruments such as common stock, preferred stock, LLC interests, and warrants. The firm typically deploys $7 million–$30 million into businesses with $20 million–$150 million of revenue and $3 million–$25 million of EBITDA, favoring minority-stake positions and “buy-and-build” or add-on acquisition strategies.
GLAD’s portfolio is sector-agnostic but concentrates on business services, light and specialty manufacturing, niche industrial products, specialty consumer goods, energy services, transportation & logistics, healthcare & education, specialty chemicals, media & communications, and aerospace & defense. Recent quarterly filings show an average portfolio leverage ratio of ~5.2× EBITDA, with a weighted-average loan yield of roughly 9.5% and a net asset value (NAV) per share of $13.20, reflecting a modest premium to its current market price of $12.80.
Key macro drivers for GLAD’s target market include the U.S. small-business credit environment (the Federal Reserve’s policy rate influences the cost of senior debt) and the ongoing demand for operational scaling in fragmented industries, where “buy-and-build” models can capture efficiency gains. The firm’s exit horizon typically spans 4–7 years, relying on strategic sales, secondary buyouts, or IPOs.
For a deeper, data-driven view of GLAD’s valuation metrics and scenario analysis, you might explore the ValueRay platform, which aggregates real-time financials and peer comparisons to help you assess the investment’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (58.1m TTM) > 0 and > 6% of Revenue (6% = 4.66m TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -1.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 49.64% (prev 5.61%; Δ 44.03pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -13.8m <= Net Income 58.1m (YES >=105%, WARN >=100%) |
| Net Debt (365.5m) to EBITDA (58.1m) ratio: 6.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 9.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.8m) change vs 12m ago 9.23% (target <= -2.0% for YES) |
| Gross Margin 74.25% (prev 81.94%; Δ -7.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 9.03% (prev 14.80%; Δ -5.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.91 (EBITDA TTM 58.1m / Interest Expense TTM 20.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.76
| (A) 0.04 = (Total Current Assets 42.9m - Total Current Liabilities 4.33m) / Total Assets 907.6m |
| (B) 0.01 = Retained Earnings (Balance) 5.20m / Total Assets 907.6m |
| (C) 0.07 = EBIT TTM 58.1m / Avg Total Assets 860.0m |
| (D) 0.01 = Book Value of Equity 5.24m / Total Liabilities 425.6m |
| Total Rating: 0.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.32
| 1. Piotroski 1.0pt |
| 2. FCF Yield -1.63% |
| 3. FCF Margin -17.71% |
| 4. Debt/Equity 0.83 |
| 5. Debt/Ebitda 6.29 |
| 6. ROIC - WACC (= 0.47)% |
| 7. RoE 11.91% |
| 8. Rev. Trend 42.04% |
| 9. EPS Trend 87.59% |
What is the price of GLAD shares?
Over the past week, the price has changed by +1.58%, over one month by +11.57%, over three months by -16.44% and over the past year by -15.54%.
Is GLAD a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GLAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.2 | 4.7% |
| Analysts Target Price | 22.2 | 4.7% |
| ValueRay Target Price | 23.7 | 11.6% |
GLAD Fundamental Data Overview December 05, 2025
P/E Trailing = 8.3137
P/E Forward = 11.2233
P/S = 5.3744
P/B = 0.9782
P/EG = 2.3116
Beta = 0.943
Revenue TTM = 77.6m USD
EBIT TTM = 58.1m USD
EBITDA TTM = 58.1m USD
Long Term Debt = unknown (none)
Short Term Debt = 397.9m USD (from shortTermDebt, last fiscal year)
Debt = 397.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 365.5m USD (from netDebt column, last quarter)
Enterprise Value = 844.5m USD (479.0m + Debt 397.9m - CCE 32.4m)
Interest Coverage Ratio = 2.91 (Ebit TTM 58.1m / Interest Expense TTM 20.0m)
FCF Yield = -1.63% (FCF TTM -13.8m / Enterprise Value 844.5m)
FCF Margin = -17.71% (FCF TTM -13.8m / Revenue TTM 77.6m)
Net Margin = 74.86% (Net Income TTM 58.1m / Revenue TTM 77.6m)
Gross Margin = 74.25% ((Revenue TTM 77.6m - Cost of Revenue TTM 20.0m) / Revenue TTM)
Gross Margin QoQ = 71.74% (prev 63.25%)
Tobins Q-Ratio = 0.93 (Enterprise Value 844.5m / Total Assets 907.6m)
Interest Expense / Debt = 1.45% (Interest Expense 5.77m / Debt 397.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.9m (EBIT 58.1m * (1 - 21.00%))
Current Ratio = 9.90 (Total Current Assets 42.9m / Total Current Liabilities 4.33m)
Debt / Equity = 0.83 (Debt 397.9m / totalStockholderEquity, last quarter 482.0m)
Debt / EBITDA = 6.29 (Net Debt 365.5m / EBITDA 58.1m)
Debt / FCF = -26.58 (negative FCF - burning cash) (Net Debt 365.5m / FCF TTM -13.8m)
Total Stockholder Equity = 487.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.40% (Net Income 58.1m / Total Assets 907.6m)
RoE = 11.91% (Net Income TTM 58.1m / Total Stockholder Equity 487.8m)
RoCE = 6.43% (EBIT 58.1m / Capital Employed (Total Assets 907.6m - Current Liab 4.33m))
RoIC = 5.76% (NOPAT 45.9m / Invested Capital 797.6m)
WACC = 5.29% (E(479.0m)/V(876.8m) * Re(8.73%) + D(397.9m)/V(876.8m) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.55%
Fair Price DCF = unknown (Cash Flow -13.8m)
EPS Correlation: 87.59 | EPS CAGR: 19.10% | SUE: 0.69 | # QB: 0
Revenue Correlation: 42.04 | Revenue CAGR: 9.57% | SUE: 3.11 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=-0.013 | Revisions Net=-1 | Analysts=7
EPS current Year (2026-09-30): EPS=1.91 | Chg30d=-0.074 | Revisions Net=-4 | Growth EPS=-5.3% | Growth Revenue=+12.5%
EPS next Year (2027-09-30): EPS=1.87 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=-2.2% | Growth Revenue=+6.6%
Additional Sources for GLAD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle